Recombinant activated factor VII (rFVIIa) in refractory haemorrhage for non-haemophiliacs: an eleven-year single-centre experience

BACKGROUND: Massive bleeding is one of the commonest salvageable causes of death. The search for an ideal haemostatic agent during massive bleeding is still ongoing. One of the novel haemostatic medications is recombinant activated factor VII (rFVIIa). To date, the usage of rFVIIa during massive hae...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Nurfatin Mohd, Chong, Soon Eu, Yusoff, Syahirah Mohamed, Mazlan, Mohd Zulfakar, Johan, Khairul Bariah, Azman, Nizuwan, Lim, Jo Anne, Mohamad, Siti Mardhiana, Noordin, Siti Salmah, Ghaffar, Zainab Abdul, Hassan, Mohd Hasyizan, Zabidi, Muhammad Azrul, Rahim, Nur Arzuar Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251212/
https://www.ncbi.nlm.nih.gov/pubmed/30498571
http://dx.doi.org/10.1186/s12878-018-0126-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251212/
https://www.ncbi.nlm.nih.gov/pubmed/30498571
http://dx.doi.org/10.1186/s12878-018-0126-z

Ejemplares similares